APO Research
Talk to an analyst

APO RESEARCH · REPORT

Shield Minimally Invasive Fascial Closure Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Shield Minimally Invasive Fascial Closure Device Market Outlook and Growth Opportunities 2026

25 December 2025195 pages

Choose your research edition.

Industry ResearchShield Minimally Invasive Fascial Closure Device Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Shield Minimally Invasive Fascial Closure Device Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Shield Minimally Invasive Fascial Closure Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Shield Minimally Invasive Fascial Closure Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Shield Minimally Invasive Fascial Closure Device Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Shield Minimally Invasive Fascial Closure Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Shield Minimally Invasive Fascial Closure Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Shield Minimally Invasive Fascial Closure Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Shield Minimally Invasive Fascial Closure Device market include EndoSystem, Dongfeng Yihe, WODELIPAI, Weipu Medical, Teleflex, Shandong Bainus Medical Instrumen, Medtronic, Longmed and Golden Stapler Surgical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Shield Minimally Invasive Fascial Closure Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Shield Minimally Invasive Fascial Closure Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Shield Minimally Invasive Fascial Closure Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Shield Minimally Invasive Fascial Closure Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Shield Minimally Invasive Fascial Closure Device Segment by Company

EndoSystem

Dongfeng Yihe

WODELIPAI

Weipu Medical

Teleflex

Shandong Bainus Medical Instrumen

Medtronic

Longmed

Golden Stapler Surgical

Double Medical Technology

Portoria Medical

Aofo

Suture Ease

CooperSurgical

Anrei Sinolinrs

Shield Minimally Invasive Fascial Closure Device Segment by Type

Shell Diameter 16mm or More

Shell Diameter 13mm-16mm

Shell Diameter 10mm-13mm

Shield Minimally Invasive Fascial Closure Device Segment by Application

Hospital

Clinic

Shield Minimally Invasive Fascial Closure Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Shield Minimally Invasive Fascial Closure Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Shield Minimally Invasive Fascial Closure Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Shield Minimally Invasive Fascial Closure Device significant trends, drivers, influence factors in global and regions.

6. To analyze Shield Minimally Invasive Fascial Closure Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Shield Minimally Invasive Fascial Closure Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Shield Minimally Invasive Fascial Closure Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Shield Minimally Invasive Fascial Closure Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Shield Minimally Invasive Fascial Closure Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Shield Minimally Invasive Fascial Closure Device industry.

Chapter 3: Detailed analysis of Shield Minimally Invasive Fascial Closure Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Shield Minimally Invasive Fascial Closure Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Shield Minimally Invasive Fascial Closure Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Shield Minimally Invasive Fascial Closure Device Industry Trends Table 2. Shield Minimally Invasive Fascial Closure Device Industry Drivers Table 3. Shield Minimally Invasive Fascial Closure Device Industry Opportunities and Challenges Table 4. Shield Minimally Invasive Fascial Closure Device Industry Restraints Table 5. Global Shield Minimally Invasive Fascial Closure Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Shield Minimally Invasive Fascial Closure Device Revenue Share by Company (2021-2026) Table 7. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Company (2021-2026) Table 9. Global Shield Minimally Invasive Fascial Closure Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Shield Minimally Invasive Fascial Closure Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Shield Minimally Invasive Fascial Closure Device Key Company Manufacturing Base & Headquarters Table 12. Global Shield Minimally Invasive Fascial Closure Device Company, Product Type & Application Table 13. Global Shield Minimally Invasive Fascial Closure Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Shield Minimally Invasive Fascial Closure Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Shell Diameter 16mm or More Table 18. Significant Companies of Shell Diameter 13mm-16mm Table 19. Significant Companies of Shell Diameter 10mm-13mm Table 20. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Type (2021-2026) Table 24. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Type (2027-2032) Table 25. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type (2021-2026) Table 29. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Application (2021-2026) Table 36. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Application (2027-2032) Table 37. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application (2021-2026) Table 41. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application (2027-2032) Table 42. Global Shield Minimally Invasive Fascial Closure Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2021-2026) & (K Units) Table 44. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Region (2021-2026) Table 45. Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2027-2032) & (K Units) Table 46. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Region (2027-2032) Table 47. Global Shield Minimally Invasive Fascial Closure Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Region (2021-2026) Table 50. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Region (2027-2032) Table 52. Global Shield Minimally Invasive Fascial Closure Device Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Shield Minimally Invasive Fascial Closure Device Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Shield Minimally Invasive Fascial Closure Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2026) & (K Units) Table 57. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Country (2021-2026) Table 58. Global Shield Minimally Invasive Fascial Closure Device Sales by Country (2027-2032) & (K Units) Table 59. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Country (2027-2032) Table 60. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Shield Minimally Invasive Fascial Closure Device Sales Value Market Share by Country (2021-2026) Table 62. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Shield Minimally Invasive Fascial Closure Device Sales Value Market Share by Country (2027-2032) Table 64. EndoSystem Company Information Table 65. EndoSystem Business Overview Table 66. EndoSystem Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. EndoSystem Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 68. EndoSystem Recent Development Table 69. Dongfeng Yihe Company Information Table 70. Dongfeng Yihe Business Overview Table 71. Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 73. Dongfeng Yihe Recent Development Table 74. WODELIPAI Company Information Table 75. WODELIPAI Business Overview Table 76. WODELIPAI Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. WODELIPAI Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 78. WODELIPAI Recent Development Table 79. Weipu Medical Company Information Table 80. Weipu Medical Business Overview Table 81. Weipu Medical Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Weipu Medical Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 83. Weipu Medical Recent Development Table 84. Teleflex Company Information Table 85. Teleflex Business Overview Table 86. Teleflex Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Teleflex Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 88. Teleflex Recent Development Table 89. Shandong Bainus Medical Instrumen Company Information Table 90. Shandong Bainus Medical Instrumen Business Overview Table 91. Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 93. Shandong Bainus Medical Instrumen Recent Development Table 94. Medtronic Company Information Table 95. Medtronic Business Overview Table 96. Medtronic Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Medtronic Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 98. Medtronic Recent Development Table 99. Longmed Company Information Table 100. Longmed Business Overview Table 101. Longmed Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Longmed Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 103. Longmed Recent Development Table 104. Golden Stapler Surgical Company Information Table 105. Golden Stapler Surgical Business Overview Table 106. Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 108. Golden Stapler Surgical Recent Development Table 109. Double Medical Technology Company Information Table 110. Double Medical Technology Business Overview Table 111. Double Medical Technology Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Double Medical Technology Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 113. Double Medical Technology Recent Development Table 114. Portoria Medical Company Information Table 115. Portoria Medical Business Overview Table 116. Portoria Medical Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Portoria Medical Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 118. Portoria Medical Recent Development Table 119. Aofo Company Information Table 120. Aofo Business Overview Table 121. Aofo Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Aofo Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 123. Aofo Recent Development Table 124. Suture Ease Company Information Table 125. Suture Ease Business Overview Table 126. Suture Ease Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Suture Ease Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 128. Suture Ease Recent Development Table 129. CooperSurgical Company Information Table 130. CooperSurgical Business Overview Table 131. CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. CooperSurgical Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 133. CooperSurgical Recent Development Table 134. Anrei Sinolinrs Company Information Table 135. Anrei Sinolinrs Business Overview Table 136. Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Product Portfolio Table 138. Anrei Sinolinrs Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Shield Minimally Invasive Fascial Closure Device Distributors List Table 142. Shield Minimally Invasive Fascial Closure Device Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Shield Minimally Invasive Fascial Closure Device Product Image Figure 2. Global Shield Minimally Invasive Fascial Closure Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Shield Minimally Invasive Fascial Closure Device Sales (2021-2032) & (K Units) Figure 5. Global Shield Minimally Invasive Fascial Closure Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Shield Minimally Invasive Fascial Closure Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Shell Diameter 16mm or More Image Figure 10. Shell Diameter 13mm-16mm Image Figure 11. Shell Diameter 10mm-13mm Image Figure 12. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Type (2021-2032) Figure 15. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Application (2021-2032) Figure 23. Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application (2021-2032) Figure 26. Global Shield Minimally Invasive Fascial Closure Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Shield Minimally Invasive Fascial Closure Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Shield Minimally Invasive Fascial Closure Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032) & (US$ Million) Figure 31. North America Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032) & (US$ Million) Figure 37. South America Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Shield Minimally Invasive Fascial Closure Device Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Shield Minimally Invasive Fascial Closure Device Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Shell Diameter 16mm or More
  • Shell Diameter 13mm-16mm
  • Shell Diameter 10mm-13mm
Applications
  • Hospital
  • Clinic
Companies covered
  • EndoSystem
  • Dongfeng Yihe
  • WODELIPAI
  • Weipu Medical
  • Teleflex
  • Shandong Bainus Medical Instrumen
  • Medtronic
  • Longmed
  • Golden Stapler Surgical
  • Double Medical Technology
  • Portoria Medical
  • Aofo
  • Suture Ease
  • CooperSurgical
  • Anrei Sinolinrs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032)
  4. 1.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales Volume (2021-2032)
  5. 1.2.3 Global Shield Minimally Invasive Fascial Closure Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Shield Minimally Invasive Fascial Closure Device Market Dynamics
  1. 2.1 Shield Minimally Invasive Fascial Closure Device Industry Trends
  2. 2.2 Shield Minimally Invasive Fascial Closure Device Industry Drivers
  3. 2.3 Shield Minimally Invasive Fascial Closure Device Industry Opportunities and Challenges
  4. 2.4 Shield Minimally Invasive Fascial Closure Device Industry Restraints
3 Shield Minimally Invasive Fascial Closure Device Market by Company
  1. 3.1 Global Shield Minimally Invasive Fascial Closure Device Company Revenue Ranking in 2025
  2. 3.2 Global Shield Minimally Invasive Fascial Closure Device Revenue by Company (2021-2026)
  3. 3.3 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Shield Minimally Invasive Fascial Closure Device Average Price by Company (2021-2026)
  5. 3.5 Global Shield Minimally Invasive Fascial Closure Device Company Ranking (2024-2026)
  6. 3.6 Global Shield Minimally Invasive Fascial Closure Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Shield Minimally Invasive Fascial Closure Device Company Product Type and Application
  8. 3.8 Global Shield Minimally Invasive Fascial Closure Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Shield Minimally Invasive Fascial Closure Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Shield Minimally Invasive Fascial Closure Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Shield Minimally Invasive Fascial Closure Device Market by Type
  1. 4.1 Shield Minimally Invasive Fascial Closure Device Type Introduction
  2. 4.1.1 Shell Diameter 16mm or More
  3. 4.1.2 Shell Diameter 13mm-16mm
  4. 4.1.3 Shell Diameter 10mm-13mm
  5. 4.2 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type
  6. 4.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type
  10. 4.3.1 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type (2021-2032)
5 Shield Minimally Invasive Fascial Closure Device Market by Application
  1. 5.1 Shield Minimally Invasive Fascial Closure Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application
  5. 5.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Shield Minimally Invasive Fascial Closure Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application
  9. 5.3.1 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application (2021-2032)
6 Shield Minimally Invasive Fascial Closure Device Regional Sales and Value Analysis
  1. 6.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2021-2032)
  3. 6.2.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Region: 2021-2026
  4. 6.2.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Region (2027-2032)
  5. 6.3 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Region (2027-2032)
  9. 6.5 Global Shield Minimally Invasive Fascial Closure Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032)
  12. 6.6.2 North America Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032)
  15. 6.7.2 Europe Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032)
  21. 6.9.2 South America Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Shield Minimally Invasive Fascial Closure Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Shield Minimally Invasive Fascial Closure Device Sales Value Share by Country, 2025 VS 2032
7 Shield Minimally Invasive Fascial Closure Device Country-level Sales and Value Analysis
  1. 7.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2032)
  4. 7.3.1 Global Shield Minimally Invasive Fascial Closure Device Sales by Country (2021-2026)
  5. 7.3.2 Global Shield Minimally Invasive Fascial Closure Device Sales by Country (2027-2032)
  6. 7.4 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Shield Minimally Invasive Fascial Closure Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Shield Minimally Invasive Fascial Closure Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Shield Minimally Invasive Fascial Closure Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Shield Minimally Invasive Fascial Closure Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 EndoSystem
  2. 8.1.1 EndoSystem Company Information
  3. 8.1.2 EndoSystem Business Overview
  4. 8.1.3 EndoSystem Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 EndoSystem Shield Minimally Invasive Fascial Closure Device Product Portfolio
  6. 8.1.5 EndoSystem Recent Developments
  7. 8.2 Dongfeng Yihe
  8. 8.2.1 Dongfeng Yihe Company Information
  9. 8.2.2 Dongfeng Yihe Business Overview
  10. 8.2.3 Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dongfeng Yihe Shield Minimally Invasive Fascial Closure Device Product Portfolio
  12. 8.2.5 Dongfeng Yihe Recent Developments
  13. 8.3 WODELIPAI
  14. 8.3.1 WODELIPAI Company Information
  15. 8.3.2 WODELIPAI Business Overview
  16. 8.3.3 WODELIPAI Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 WODELIPAI Shield Minimally Invasive Fascial Closure Device Product Portfolio
  18. 8.3.5 WODELIPAI Recent Developments
  19. 8.4 Weipu Medical
  20. 8.4.1 Weipu Medical Company Information
  21. 8.4.2 Weipu Medical Business Overview
  22. 8.4.3 Weipu Medical Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Weipu Medical Shield Minimally Invasive Fascial Closure Device Product Portfolio
  24. 8.4.5 Weipu Medical Recent Developments
  25. 8.5 Teleflex
  26. 8.5.1 Teleflex Company Information
  27. 8.5.2 Teleflex Business Overview
  28. 8.5.3 Teleflex Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teleflex Shield Minimally Invasive Fascial Closure Device Product Portfolio
  30. 8.5.5 Teleflex Recent Developments
  31. 8.6 Shandong Bainus Medical Instrumen
  32. 8.6.1 Shandong Bainus Medical Instrumen Company Information
  33. 8.6.2 Shandong Bainus Medical Instrumen Business Overview
  34. 8.6.3 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Bainus Medical Instrumen Shield Minimally Invasive Fascial Closure Device Product Portfolio
  36. 8.6.5 Shandong Bainus Medical Instrumen Recent Developments
  37. 8.7 Medtronic
  38. 8.7.1 Medtronic Company Information
  39. 8.7.2 Medtronic Business Overview
  40. 8.7.3 Medtronic Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Medtronic Shield Minimally Invasive Fascial Closure Device Product Portfolio
  42. 8.7.5 Medtronic Recent Developments
  43. 8.8 Longmed
  44. 8.8.1 Longmed Company Information
  45. 8.8.2 Longmed Business Overview
  46. 8.8.3 Longmed Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Longmed Shield Minimally Invasive Fascial Closure Device Product Portfolio
  48. 8.8.5 Longmed Recent Developments
  49. 8.9 Golden Stapler Surgical
  50. 8.9.1 Golden Stapler Surgical Company Information
  51. 8.9.2 Golden Stapler Surgical Business Overview
  52. 8.9.3 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Golden Stapler Surgical Shield Minimally Invasive Fascial Closure Device Product Portfolio
  54. 8.9.5 Golden Stapler Surgical Recent Developments
  55. 8.10 Double Medical Technology
  56. 8.10.1 Double Medical Technology Company Information
  57. 8.10.2 Double Medical Technology Business Overview
  58. 8.10.3 Double Medical Technology Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Double Medical Technology Shield Minimally Invasive Fascial Closure Device Product Portfolio
  60. 8.10.5 Double Medical Technology Recent Developments
  61. 8.11 Portoria Medical
  62. 8.11.1 Portoria Medical Company Information
  63. 8.11.2 Portoria Medical Business Overview
  64. 8.11.3 Portoria Medical Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Portoria Medical Shield Minimally Invasive Fascial Closure Device Product Portfolio
  66. 8.11.5 Portoria Medical Recent Developments
  67. 8.12 Aofo
  68. 8.12.1 Aofo Company Information
  69. 8.12.2 Aofo Business Overview
  70. 8.12.3 Aofo Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Aofo Shield Minimally Invasive Fascial Closure Device Product Portfolio
  72. 8.12.5 Aofo Recent Developments
  73. 8.13 Suture Ease
  74. 8.13.1 Suture Ease Company Information
  75. 8.13.2 Suture Ease Business Overview
  76. 8.13.3 Suture Ease Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Suture Ease Shield Minimally Invasive Fascial Closure Device Product Portfolio
  78. 8.13.5 Suture Ease Recent Developments
  79. 8.14 CooperSurgical
  80. 8.14.1 CooperSurgical Company Information
  81. 8.14.2 CooperSurgical Business Overview
  82. 8.14.3 CooperSurgical Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 CooperSurgical Shield Minimally Invasive Fascial Closure Device Product Portfolio
  84. 8.14.5 CooperSurgical Recent Developments
  85. 8.15 Anrei Sinolinrs
  86. 8.15.1 Anrei Sinolinrs Company Information
  87. 8.15.2 Anrei Sinolinrs Business Overview
  88. 8.15.3 Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Anrei Sinolinrs Shield Minimally Invasive Fascial Closure Device Product Portfolio
  90. 8.15.5 Anrei Sinolinrs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Shield Minimally Invasive Fascial Closure Device Value Chain Analysis
  2. 9.1.1 Shield Minimally Invasive Fascial Closure Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Shield Minimally Invasive Fascial Closure Device Sales Mode & Process
  6. 9.2 Shield Minimally Invasive Fascial Closure Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Shield Minimally Invasive Fascial Closure Device Distributors
  9. 9.2.3 Shield Minimally Invasive Fascial Closure Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst